Rare Diseases
Testing treatments to improve symptoms of Myositis
Myositis is a disorder in which the immune system attacks the muscles. It is hoped that this new treatment may help improve the symptoms of this disease.
Research Objectives
Status
Recruitment
Patient Group
Study location
Phase
Study type
Lead investigator
- Dr Daman Langguth
Clinical trial coordinator
- Venita Bali
Technical title
A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathies
About this research project
The research project is testing a new treatment for Active Idiopathic Inflammatory Myopathy. This is a disorder in which the immune system attacks the muscles. This leads to muscle weakness and may affect other organs of the body.
The potential new treatment being tested is called efgartigimod (also called ARGX113). It is hoped that efgartigimod may help improve the symptoms of myositis.
Latest News
Webinar- Coeliac Disease: Rethinking Gluten Thresholds
Australia’s First Medical Research Giving Day Raises More Than $1.5 million!
